U.S. Renewable Energy Stock News

BlackSky Technology (BKSY) just landed a multi-year contract worth over $30 million to deliver its Gen-3 tactical ISR services to a strategic international defense customer. This move highlights the company’s growing position in the defense intelligence market. See our latest analysis for BlackSky Technology. BlackSky’s shares have been volatile, with the recent $30 million contract announcement offering a bright spot amid pressure from slowing revenue growth and widening losses reported last...

Wondering if Axon Enterprise is trading at a fair price, or if there's hidden value waiting to be unearthed? You're not alone, and today's market makes this question more interesting than ever. The stock has seen a wild ride lately, down 5.1% over the last week and falling 20.9% over the past month. Viewed over a longer period, it is still an impressive 190% higher than three years ago. Recent headlines have focused on Axon's advances in public safety technology and...

Dropbox (DBX) caught investors’ attention after reporting third quarter results that showed improved profitability and strong retention rates. The company also raised its full-year 2025 revenue guidance. This updated outlook is fueling fresh discussion around its growth prospects. See our latest analysis for Dropbox. The upbeat quarterly report and new AI-driven product momentum have reignited interest in Dropbox, with the share price gaining over 6% in the past week and a 9% total return for...

On November 10, 2025, Autoliv, Inc. announced a 2.4% increase to its quarterly dividend for the fourth quarter, raising it to US$0.87 per share, with annualized payouts reaching approximately US$260 million. This latest dividend increase highlights Autoliv's continued focus on shareholder returns and signals confidence in its financial position and outlook. We'll examine how this dividend increase strengthens Autoliv's investment narrative, especially regarding its ongoing commitment to...

Sterling Infrastructure (STRL) caught investor attention after reporting strong third quarter results, with sales and net income both rising compared to last year. The company also raised its full-year 2025 earnings outlook. See our latest analysis for Sterling Infrastructure. Despite surging to new highs earlier this quarter, Sterling Infrastructure’s share price has recently pulled back, dropping 14% in a single day and nearly 16% over the past week. That said, even with this volatility and...

Collegium Pharmaceutical, Inc. reported that for the third quarter ended September 30, 2025, net income rose to US$31.51 million from US$9.34 million a year earlier, and raised full-year 2025 net product revenue guidance to US$775–785 million. This combination of substantially higher quarterly profits and increased revenue projections provides an updated view of the company's financial momentum and outlook. Given the boost in quarterly earnings and upgraded revenue guidance, we'll assess how...

Ever wondered if Illumina could be a hidden gem, potentially undervalued and offering an opportunity that others might be missing? Despite a recent 29.0% surge over the past month, Illumina's stock is still down -8.4% year-to-date and trails its levels from one and five years ago. News around the company has been lively, with investors reacting to developments in Illumina's strategy and leadership. Recent headlines have spotlighted board changes and ongoing discussions about its future...

Key Insights BJ's Restaurants' estimated fair value is US$32.04 based on 2 Stage Free Cash Flow to Equity With US$37.20...

Amphenol (APH) stock has been on the radar for many investors, driven by its steady growth figures over the past year. The company’s strong financial trajectory continues to spark interest among those following the tech hardware sector. See our latest analysis for Amphenol. After a rapid climb throughout the year, Amphenol’s share price currently sits at $135.25 following a recent dip. This marks a notable 96% year-to-date share price return. The momentum has been especially pronounced over...

Wondering if Teledyne Technologies is fairly valued or a hidden gem? You are not alone, especially if you follow stocks with strong long-term potential and quality fundamentals. Teledyne’s stock has shown resilience, edging up 10.4% year-to-date despite a recent dip of 11.6% over the past month that has caught some investors’ attention. Recent headlines highlight Teledyne’s continued investment in sensor and instrumentation technology, as well as high-profile contract wins that strengthen...

Wondering if PayPal’s stock is actually a bargain, or if it’s still playing catch-up? You’re not alone. The real answer might be hiding in plain sight. The share price has slipped recently, dropping 1.4% over the past week and 5.5% in the last month. It’s down nearly 24% since the start of the year. Much of this volatility has played out as the market digests shifting sentiment around digital payments. Headlines have highlighted intense competition from fintech newcomers and scrutiny over...

Guardant Health (GH) shares have seen significant movement lately, catching the attention of investors interested in innovative healthcare stocks. Over the past month, the stock has surged around 50 percent, reflecting a busy stretch for the genomics firm. See our latest analysis for Guardant Health. Guardant Health’s recent rally caps off an extraordinary year, as the company’s 1-year total shareholder return has soared 211.6 percent. The strong 30-day share price return hints at growing...

NextNRG Inc. announced it would report its third quarter 2025 earnings on November 14, 2025, giving investors a key update on operational progress and financial performance. This scheduled release comes as market participants seek more insight into the company's expanding integrated energy offerings and increasing project pipeline. With the Q3 results now released, we'll examine how expectations for improved operational metrics and business scale could influence NextNRG's investment...

CRH (NYSE:CRH) just released its third quarter results, reporting gains in both revenue and net income compared to last year. The company also increased its quarterly dividend and completed a large share buyback. See our latest analysis for CRH. CRH’s latest quarterly update, with double-digit net income growth and a bigger dividend, arrives after a year of robust share price momentum. The stock is now up nearly 20% so far in 2025. Long-term holders have seen the real rewards as well, with a...

Equifax (EFX) has rolled out a new set of AI-powered anti-money laundering compliance solutions tailored for financial institutions. The platform combines machine learning with comprehensive global list screening to help firms manage growing regulatory requirements more effectively and efficiently. See our latest analysis for Equifax. The launch of Equifax’s new AI-driven compliance platform comes at a time when its stock has seen some pressure, with a recent 1-year total shareholder return...

Corteva (CTVA) delivered upbeat third quarter results and boosted its full-year outlook, with management now expecting both sales and earnings growth for 2025. The company also detailed plans to spin off its seeds business in 2026, marking a major transformation. See our latest analysis for Corteva. Corteva's upbeat earnings, new product launches, and plans for a seeds business spin-off have powered a notable recovery in sentiment, helping drive a 17.5% share price return year-to-date. While...

Wondering if Reddit stock is truly a bargain or just getting swept up in the buzz? You are not alone, as plenty of investors are debating its real value right now. In the past year, Reddit shares have jumped 43.6%. Even in the last week alone, the stock moved up 3.1%, hinting at lots of shifting sentiment and growth potential. News of Reddit expanding partnerships with AI companies and rolling out new ad formats has fueled the stock’s momentum. Investors hope these moves will unlock more...

Earlier this week, Alnylam Pharmaceuticals announced and presented new post hoc analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), revealing amyloid regression in 22% of treated patients and preservation of kidney function, with a consistent safety profile demonstrated among those with advanced chronic kidney disease. This reinforces AMVUTTRA’s established efficacy as a multi-organ RNAi therapeutic, potentially highlighting its differentiation in treating...

eXp World Holdings reported third quarter 2025 results showing a return to profitability with net income of US$3.5 million, 7% year-over-year revenue growth to US$1.32 billion, and declared a US$0.05 per share dividend for the fourth quarter, payable December 1, 2025. The company also introduced its AI-powered business assistant, Mira, and continued expanding both its international presence and agent network, signaling a focus on technology and global growth drivers. We'll examine how eXp's...

Joby Aviation and L3Harris Technologies recently completed the first flight of Joby’s hybrid-electric, autonomous vertical takeoff and landing demonstrator, targeting both defense and future commercial applications. This milestone marks Joby Aviation’s entry into hybrid powertrain technology, expanding its platform beyond all-electric air taxis and opening new opportunities in military logistics and extended-range air mobility. Let’s explore how this hybrid demonstrator milestone reshapes...

TTM Technologies recently reported that from July 1, 2025 to September 29, 2025, it did not repurchase any shares under its buyback program announced in May 2025, while management outlined expansion plans for advanced PCB manufacturing in China and a renewed focus on higher value-added segments during a non-deal roadshow. This renewed operational focus aligns with growing investor interest in value-oriented technology companies, particularly as industry caution mounts regarding...

Avadel Pharmaceuticals (AVDL) just announced third quarter and nine-month earnings results, showing a move from net losses to net income in both periods compared to last year. This jump highlights ongoing financial improvement and hints at a meaningful turnaround for the company. See our latest analysis for Avadel Pharmaceuticals. Shares of Avadel Pharmaceuticals have steadily gathered momentum in recent months, with a 30-day share price return of nearly 34% and a striking year-to-date gain...

Ever wondered if Uber Technologies is actually worth its current price, or if there is more value hidden in the stock than meets the eye? Uber’s stock has seen significant momentum, gaining 45.3% year-to-date and 217.8% over the past three years, despite a slight recent pullback. Recent headlines highlight Uber’s continued expansion efforts, with the company announcing a fresh partnership with businesses to broaden delivery services and deepen its presence across global markets. These...

Wondering if Deere is a smart buy at today’s price? You’re not alone, and knowing what’s fair value here could make all the difference for your portfolio. The stock has climbed an impressive 13.2% year-to-date and is up 21.6% over the past year, despite dipping slightly this week. Market buzz lately has focused on Deere’s push into precision agriculture technology and strategic partnerships. These moves have caught both investors' and industry watchers' eyes. These developments are shaping...